Globe Life (NYSE:GL) Issues FY25 Earnings Guidance

Globe Life (NYSE:GL) issued an update on its FY25 earnings guidance on Wednesday morning. The company provided EPS guidance of $13.20-13.90 for the period, compared to the consensus EPS estimate of $13.25. Globe Life also updated its FY 2024 guidance to 12.200-12.400 EPS.

Globe Life Stock Down 3.9 %

GL stock opened at $105.15 on Friday. The company has a 50 day moving average of $105.37 and a two-hundred day moving average of $90.88. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.31. Globe Life has a 12-month low of $38.95 and a 12-month high of $132.00. The company has a market cap of $9.47 billion, a price-to-earnings ratio of 10.04 and a beta of 0.81.

Globe Life (NYSE:GL) last issued its earnings results on Wednesday, October 23rd. The company reported $3.49 EPS for the quarter, beating analysts’ consensus estimates of $3.06 by $0.43. Globe Life had a return on equity of 21.93% and a net margin of 18.47%. The firm had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.46 billion. During the same quarter in the previous year, the company posted $2.71 earnings per share. The business’s quarterly revenue was up 5.1% compared to the same quarter last year. On average, equities analysts anticipate that Globe Life will post 11.93 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Friday, October 4th will be given a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a yield of 0.91%. The ex-dividend date of this dividend is Friday, October 4th. Globe Life’s payout ratio is presently 9.17%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on GL shares. Morgan Stanley lifted their price objective on shares of Globe Life from $110.00 to $120.00 and gave the company an “equal weight” rating in a research note on Thursday. Jefferies Financial Group upped their price target on Globe Life from $85.00 to $88.00 and gave the stock a “hold” rating in a research note on Friday, June 28th. Truist Financial raised their price objective on Globe Life from $90.00 to $105.00 and gave the company a “hold” rating in a research note on Friday. Raymond James upped their target price on Globe Life from $160.00 to $188.00 and gave the stock a “strong-buy” rating in a research report on Tuesday, October 15th. Finally, Piper Sandler upped their price objective on shares of Globe Life from $118.00 to $130.00 and gave the stock an “overweight” rating in a report on Friday. Five analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $123.80.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.